Clywedog Therapeutics
Phase 1Targeting escape mutations in hematological cancers with first and best in class medicines.
Founded
2020
Focus
Small Molecules
About
Targeting escape mutations in hematological cancers with first and best in class medicines.
Company Info
TypePrivate
Founded2020
LocationCambridge, United Kingdom
StagePhase 1
Contact
SIMILAR COMPANIES
Abbexa
Pre-clinical · Cambridge
Accentus Medical
Pre-clinical · Oxford
AbOliGo
Pre-clinical · London
Bigespas
Pre-clinical · London
Actimed Therapeutics
Pre-clinical · London
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile